Evidence map›Paper›PMID 31206518›Full record

ArticlePLoS neglected tropical diseases2019

Giardia lamblia miRNAs as a new diagnostic tool for human giardiasis.

Tal Meningher, Daniel Boleslavsky, Iris Barshack, Hila Tabibian-Keissar, Refael Kohen, Devorah Gur-Wahnon, Iddo Z Ben-Dov, Yechezkel Sidi, Dror Avni, Eli Schwartz

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in PLoS neglected tropical diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. The Exosome-like Vesicles ofInternational journal of molecular sciences · 2023
    Article
  4. Review
  5. Disease Biomarkers of Giardiasis.Journal of parasitology research · 2022
    Review
  6. Parasite-derived microRNAs as a diagnostic biomarker: potential roles, characteristics, and limitations.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2021
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Tal MeningherLaboratory of Molecular Cell Biology, Sheba Medical Center, Ramat Gan, Israel.
Daniel BoleslavskyDepartment of Medicine C, Sheba Medical Center, Ramat Gan, Israel.
Iris BarshackDepartment of Pathology, Sheba Medical Center, Ramat Gan, Israel.
Hila Tabibian-KeissarDepartment of Pathology, Sheba Medical Center, Ramat Gan, Israel.
Refael KohenIsrael National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel.
Devorah Gur-WahnonLaboratory of Medical Transcriptomics, Nephrology and Hypertension Services, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Iddo Z Ben-DovLaboratory of Medical Transcriptomics, Nephrology and Hypertension Services, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.ORCID 0000-0002-9180-3604
Yechezkel SidiLaboratory of Molecular Cell Biology, Sheba Medical Center, Ramat Gan, Israel.
Dror AvniLaboratory of Molecular Cell Biology, Sheba Medical Center, Ramat Gan, Israel.ORCID 0000-0002-8738-1840
Eli SchwartzMolecular Laboratory for the Study of Tropical Diseases, Sheba Medical Center, Ramat Gan, Israel.
Sheba Medical Center · ILTel Aviv University · ILHadassah Medical Center · ILBar-Ilan University · ILWeizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGiardia lamblia is a very common cause of gastrointestinal symptoms worldwide. There are several methods for the diagnosis of Giardia infection, however none are ideal. We aim to find a new, microRNA-based method that will improve the currently available diagnostic methods for giardiasis.

methodsDeep-sequence profiling of Giardia small-RNA revealed that miR5 and miR6 are highly expressed in Giardia. These miRNAs were tested by qRT-PCR in duodenal biopsies of patients with giardiasis who were positive by microscopic pathological evaluation. The gastric biopsies of the same patients served as negative control tissues. Additionally, these miRNAs were evaluated in stool samples of patients with proven giardiasis.

resultsAll histologically proven duodenal biopsies of patients with Giardia infection were positive for Giardia miR5, with a mean threshold cycle (Ct) of 23.7, as well as for Giardia DNA qPCR (16S-like gene, mean Ct 26.3). Gastric biopsies which were tested as a control all were negative. Stool evaluation of miR6 in patients with giardiasis showed 90% specificity but only 66% sensitivity, and a lower accuracy rate was obtained with miR5.

conclusionGiardia miR5 testing in duodenal biopsies may be a new method for the diagnosis of giardiasis. It seems to be more sensitive when compared with testing for Giardia DNA by qPCR in duodenal biopsies. It will be important to investigate the contribution of routine Giardia miRNA testing in duodenal biopsies from patients with persistent abdominal symptoms.

Indexed as

BiopsyDuodenumFecesFemaleGiardia lambliaGiardiasisHumansInfantInfant, NewbornMaleMicroRNAsRNA, ProtozoanSensitivity and SpecificityMicroRNAsRNA, Protozoan

Identifiers

PMID31206518
PMCPMC6597124
OpenAlexW2952033957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.